Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Kozal

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
AIDS Patient Care and Stds|May 15, 2004
Cross-resistance patterns among HIV protease inhibitorsMichael Kozal
Academic Medicine : Journal of the Association of American Medical Colleges|May 4, 2022
Academic Medical Centers and the U.S. Department of Veterans Affairs: A 75-Year Partnership Influences Medical Education, Scientific Discovery, and Clinical CareIsmene L Petrakis, Michael Kozal
Expert Review of Anti-Infective Therapy|December 17, 2020
Fostemsavir for the treatment of HIVNikhil Seval, Cynthia Frank, Michael Kozal
HIV Clinical Trials|October 25, 2007
Evolution of genotypic resistance algorithms and their impact on the interpretation of clinical trials: an OPTIMA trial substudySamit Desai, Tassos Kyriakides, Mark Holodniy, et al.
Journal of the International Association of Providers of AIDS Care|December 2, 2016
Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based StudyElie Helou, Sheela Shenoi, Tassos Kyriakides, et al.
AIDS and Behavior|February 14, 2013
A study of financial incentives to reduce plasma HIV RNA among patients in careSteven Farber, Janet Tate, Cyndi Frank, et al.
Plos One|February 23, 2012
Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencingMax Lataillade, Jennifer Chiarella, Rong Yang, et al.
Plos One|June 10, 2010
Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE studyMax Lataillade, Jennifer Chiarella, Rong Yang, et al.
Plos One|August 7, 2020
SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?Daniel G Federman, Shaili Gupta, Gary Stack, et al.
Journal of Medical Virology|December 13, 2019
Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disordersMichael Fuchs, Alexander Monto, Norbert Bräu, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
AIDS Patient Care and Stds|May 15, 2004
Cross-resistance patterns among HIV protease inhibitorsMichael Kozal
Academic Medicine : Journal of the Association of American Medical Colleges|May 4, 2022
Academic Medical Centers and the U.S. Department of Veterans Affairs: A 75-Year Partnership Influences Medical Education, Scientific Discovery, and Clinical CareIsmene L Petrakis, Michael Kozal
Expert Review of Anti-Infective Therapy|December 17, 2020
Fostemsavir for the treatment of HIVNikhil Seval, Cynthia Frank, Michael Kozal
HIV Clinical Trials|October 25, 2007
Evolution of genotypic resistance algorithms and their impact on the interpretation of clinical trials: an OPTIMA trial substudySamit Desai, Tassos Kyriakides, Mark Holodniy, et al.
Journal of the International Association of Providers of AIDS Care|December 2, 2016
Characterizing Patients with Very-Low-Level HIV Viremia: A Community-Based StudyElie Helou, Sheela Shenoi, Tassos Kyriakides, et al.
AIDS and Behavior|February 14, 2013
A study of financial incentives to reduce plasma HIV RNA among patients in careSteven Farber, Janet Tate, Cyndi Frank, et al.
Plos One|February 23, 2012
Virologic failures on initial boosted-PI regimen infrequently possess low-level variants with major PI resistance mutations by ultra-deep sequencingMax Lataillade, Jennifer Chiarella, Rong Yang, et al.
Plos One|June 10, 2010
Prevalence and clinical significance of HIV drug resistance mutations by ultra-deep sequencing in antiretroviral-naïve subjects in the CASTLE studyMax Lataillade, Jennifer Chiarella, Rong Yang, et al.
Plos One|August 7, 2020
SARS-CoV-2 detection in setting of viral swabs scarcity: Are MRSA swabs and viral swabs equivalent?Daniel G Federman, Shaili Gupta, Gary Stack, et al.
Journal of Medical Virology|December 13, 2019
Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disordersMichael Fuchs, Alexander Monto, Norbert Bräu, et al.
Pageof 2